Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study

Evaluation of Plasma Circulating Cell Free DNA Concentration and Integrity in Patients with Prostate Cancer in Jamaica: A Preliminary Study

Background: Cell free circulating DNA (cfcDNA) is a promising diagnostic tool for prostate cancer (PCa). This study aimed to measure the cfcDNA concentration and integrity in PCa patients using quantitative polymerase chain reaction (qPCR) analysis. This study also assessed the correlation between t...

Full description

Bibliographic Details
Main Authors:	Andrew Condappa, Donovan McGrowder, William Aiken, Wayne McLaughlin, Maxine Gossell-Williams
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Diseases
Subjects:	cell free circulating DNA prostate cancer integrity
Online Access:	https://www.mdpi.com/2079-9721/8/3/34

Similar Items

Clinical and laboratory findings in patients with leptospirosis at a tertiary teaching hospital in Jamaica
by: Donovan McGrowder, et al.
Published: (2010-11-01)

Circulating Tumor Cells in Prostate Cancer
by: Brian Hu, et al.
Published: (2013-12-01)

Perioperative Search for Circulating Tumor Cells in Patients Undergoing Prostate Brachytherapy for Clinically Nonmetastatic Prostate Cancer
by: Hideyasu Tsumura, et al.
Published: (2017-01-01)

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
by: Theodore Gourdin, et al.
Published: (2018-01-01)

A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group
by: Brian D. Kelly, et al.
Published: (2015-07-01)

Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer
by: Bianca C. T. Flores, et al.
Published: (2021-08-01)

Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
by: Gerit Theil, et al.
Published: (2021-07-01)

Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management
by: Oscar Goodman, et al.
Published: (2014-03-01)

Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform
by: Giuseppe Albino, et al.
Published: (2013-12-01)

Epidemiological Features of violence-related Injuries in Jamaica
by: Tazhmoye V. Crawford, et al.
Published: (2014-11-01)

Prospective Study of the Clinical Impact of Epithelial and Mesenchymal Circulating Tumor Cells in Localized Prostate Cancer
by: Liu H, et al.
Published: (2020-06-01)

When Prostate Cancer Circulates in the Bloodstream
by: Virginie Vlaeminck-Guillem
Published: (2015-10-01)

Three dimensional telomeric profiles in circulating tumour cells as a method of monitoring treatment response in high-risk prostate cancer patients
by: Wark, Landon, et al.
Published: (2016)

Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
by: Lucile Broncy, et al.
Published: (2019-07-01)

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
by: Karin Ried, et al.
Published: (2020-04-01)

Isolation and characterization of circulating tumor cells in prostate cancer
by: Elan Shlomo Diamond, et al.
Published: (2012-10-01)

Environmental Risk Factors Associated with Leptospirosis among Butchers and Their Associates in Jamaica
by: PD Brown, et al.
Published: (2010-12-01)

Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
by: Hisamitsu Ide, et al.
Published: (2014-09-01)

Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer
by: Michael Ladurner, et al.
Published: (2021-08-01)

The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial
by: Gráinne Sheill, et al.
Published: (2017-10-01)

Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
by: Gerit Theil, et al.
Published: (2020-12-01)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
by: Luis León-Mateos, et al.
Published: (2016-09-01)

Screening and identification of differentially expressed transcripts in circulating cells of prostate cancer patients using suppression subtractive hybridization
by: Manatt C Scott, et al.
Published: (2005-08-01)

Influence of obesity and androgen deficiency on prostatic blood circulation
by: I. A. Tyuzikov, et al.
Published: (2012-04-01)

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel
by: Ingeborg E. de Kruijff, et al.
Published: (2019-08-01)

Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer
by: Natalie A. Lockney, MD, et al.
Published: (2020-09-01)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
by: Shenyi Lian, et al.
Published: (2021-10-01)

Current status of liquid biopsies for the detection and management of prostate cancer
by: Lu YT, et al.
Published: (2019-06-01)

Detection and Isolation of Circulating Tumor Cells in Urologic Cancers: A Review
by: Robert D. Loberg, et al.
Published: (2004-07-01)

Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)
by: Brian Hayes, et al.
Published: (2021-09-01)

Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance
by: Jiwoong Yu, et al.
Published: (2021-03-01)

Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy
by: C. Hoey, et al.
Published: (2019-05-01)

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
by: Marianne Trier Bjerre, et al.
Published: (2020-05-01)

Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report
by: Junji Kitamura, et al.
Published: (2021-09-01)

Trace Elements and Chronic Kidney Disease: A Cross-Sectional Study from Jamaica
by: Adwalia Fevrier-Paul, et al.
Published: (2021-07-01)

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer
by: Wojciech A. Cieślikowski, et al.
Published: (2020-01-01)

In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy
by: Shukun Chen, et al.
Published: (2019-07-01)

Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer
by: Tian Zhang, et al.
Published: (2021-02-01)

Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
by: Ingrid Jenny Guldvik, et al.
Published: (2021-06-01)

Improved Prognostic Stratification Using Circulating Tumor Cell Clusters in Patients with Metastatic Castration-Resistant Prostate Cancer
by: Chun Wang, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_edsq1fob3olkvu8bq4oe04ujer